CE

STMicroelectronics and SEONG JI INDUSTRIAL announce new LPWA module using STM32 wireless microcontroller

Retrieved on: 
Monday, April 4, 2022
LPWAN, Marketing, SOC, CE, RC4, STM32, MDG, Internet, NYSE, RC3, LPWA, Tracker, Digital marketing, LoRa, RC6, Carbon, FCC, OEM, ST, Patent, RC1, IOT, RC2, Solution, Electronics, R, LSM, RC5, Efficiency, STM, STMicroelectronics, United States patent law, Video game console, Renewable energy, Mobile phone, EU

These modules are also available in API (application programming interface)-enabled variants that allow the integration of the customers firmware inside the module.

Key Points: 
  • These modules are also available in API (application programming interface)-enabled variants that allow the integration of the customers firmware inside the module.
  • The LSM100A/110A module size is 14.0mm x 15.0mm x2.8mm with the half-through hole type for easy soldering on the customers board.
  • STM32 is a registered and/or unregistered trademark of STMicroelectronics International NV or its affiliates in the EU and/or elsewhere.
  • As well as module business, we are supporting OEM/ODM business together for the global customers with cost-effective and highly qualified service.

Customer Experience Management Market with COVID-19 Impact, by Component, Touchpoint, Deployment Type, Organization Size, Vertical and Region - Global Forecast to 2026 - ResearchAndMarkets.com

Retrieved on: 
Friday, April 1, 2022
Other Health, Software, Networks, Other Retail, Data Management, Other Travel, Technology, Travel, Security, Retail, Telecommunications, Health, Cloud, Adoption, CAGR, Organization, Solution, Compound annual growth rate, CEM, Population, Artificial intelligence, City centre, USD, Social media, CE, Machine learning, Retail

The global Customer experience management Market size to grow from USD 9.5 Billion in 2021 to USD 16.9 Billion by 2026, at a Compound Annual Growth Rate (CAGR) of 12.3% during the forecast period.

Key Points: 
  • The global Customer experience management Market size to grow from USD 9.5 Billion in 2021 to USD 16.9 Billion by 2026, at a Compound Annual Growth Rate (CAGR) of 12.3% during the forecast period.
  • In the customer experience management market by component, the services is expected to record a higher growth rate during the forecast period.
  • The overall services segment has a major influence on the customer experience management market's growth.
  • These services assist end users in reducing overall costs, increasing overall revenues, and improving business performance.

Affluent Medical : 2021 full-year results and update on clinical programs.

Retrieved on: 
Friday, April 1, 2022
Mitral insufficiency, Company, Recurrence, Heart, Population, EFS, Marketing, CE, Trial of the century, Death, Mortality, Incontinence, Mitral valve, Breakthrough therapy, Urinary incontinence, Program, Pathology, Woman, Hospital, Incidence, Degenerative disease, Man, Czech Republic, Voltage optimisation, Quality of life, Safety, COVID-19, Ethics, FDA, Patient, Medical imaging, Medical device, Pet, Pharmaceutical industry, Medtech, Kalio

According to Affluent Medical estimates, fewer than 4% of the 4 million patients with severe mitral insufficiency benefit from surgery.

Key Points: 
  • According to Affluent Medical estimates, fewer than 4% of the 4 million patients with severe mitral insufficiency benefit from surgery.
  • [6]
    Affluent Medical is currently developing two medical devices to address the treatment of mitral insufficiency: Kalios and Epygon.
  • Following the positive results of the Optimise study, Affluent Medical initiated a clinical study, Optimise II pivotal for its Kalios device.
  • Affluent Medical develops innovative, next-generation minimally invasive implants to restore essential physiological functions in these areas.

Microbix Announces Annual and Special Meeting Voting Results

Retrieved on: 
Thursday, March 31, 2022
Company, Medical device, Organization, TGA, U.S. FDA, OTCQX, CE, ISO 9001, Antigen, Health, TSX, Ernst & Young, Goal, Health Canada, Solution, News, FDA, Engineering

Microbix develops proprietary biological technology solutions for human health and well-being, with over 100 skilled employees and sales nearing C$ 2.0 million per month.

Key Points: 
  • Microbix develops proprietary biological technology solutions for human health and well-being, with over 100 skilled employees and sales nearing C$ 2.0 million per month.
  • Microbix antigens enable the antibody tests of over 100 international diagnostics companies, while its QAPs are sold to clinical laboratory accreditation organizations, diagnostics companies, and clinical laboratories.
  • Microbix is ISO 9001 and 13485 accredited, U.S. FDA registered, Australian TGA registered, Health Canada establishment licensed, and provides CE marked products.
  • Accordingly, actual future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information.

Aveta.Life Collaborates with ADM Tronics for Regulatory Development

Retrieved on: 
Tuesday, March 29, 2022
Private Securities Litigation Reform Act, Company, CE, Performing Life, Inc, Life, Research, SEC, US FDA, CEO, CTO, Health, Mary Dimino, Laboratory, Technology, US, GLOBE, Physician, OTCQB, Union, Aveta, ADM, News, Medical device, FDA, History, Pharmaceutical industry, Engineering

Northvale, NJ, March 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- ADM Tronics Unlimited, Inc. (OTCQB - ADMT) announced that Aveta.Life Inc, www.aveta.life a startup company with a mission to improve women’s health by developing an innovative platform for hormonal diagnostic testing, will receive regulatory development guidance and oversight provided by ADMT.

Key Points: 
  • Andre DiMino, CEO of ADMT, with over four decades of experience in medical device development and regulatory compliance, has agreed to join the Aveta.Life Advisory Board.
  • The collaboration between Aveta.Life and ADMT will ensure that the development path for the Hormonometer system will meet regulatory requirements for US FDA, CE certifications for the European Union and other regulatory specifications.
  • At a recent meeting convened at ADM Tronics FDA-Registered facility in Northvale, NJ, Aveta.Life launched the regulatory pathway requirements for development activities being undertaken by Aveta.Life researchers and scientists.
  • ADMT welcomes inquiries for its medical device development, regulatory and manufacturing services at www.admtronics.com .

Microbix Invests to Further Scale Its Business

Retrieved on: 
Tuesday, March 29, 2022
Company, Medical device, Organization, TGA, U.S. FDA, Investment, OTCQX, CE, Laboratory information management system, ISO 9001, Growth, Medtech, QMS, Antigen, Enterprise resource planning, Health, TSX, Prospectus, Documentation, ISO13485, DXTM, Goal, Health Canada, GLOBE, Quality management system, Solution, News, NetSuite, ERP, FDA, Engineering, ISO9001

These initiatives will support more rapid growth in each of Microbixs business lines its test ingredients business (antigens), its test Quality Assessment Products (QAPs), and its Viral Transport Medium (DxTM).

Key Points: 
  • These initiatives will support more rapid growth in each of Microbixs business lines its test ingredients business (antigens), its test Quality Assessment Products (QAPs), and its Viral Transport Medium (DxTM).
  • Microbix currently operates a stringent, but paper-based ISO9001 and ISO13485 QMS appropriate for the highly-regulated markets in which it operates.
  • Dr. Ken Hughes, Microbixs Chief Operating Officer, commented, Our current QMS/ERP solutions have ably supported Microbix over the last several years.
  • Microbix is ISO 9001 and 13485 accredited, U.S. FDA registered, Australian TGA registered, Health Canada establishment licensed, and provides CE marked products.

Celanese and Mitsubishi Gas Chemical Complete Restructuring of Korea Engineering Plastics JV

Retrieved on: 
Thursday, March 31, 2022
Engineering, Chemicals, Plastics, Other Manufacturing, Manufacturing, KEP, Company, Mission statement, EPS, Marketing, CE, Mitsubishi Gas Chemical Company, NYSE, GAAP, Public expenditure, Hardness, Risk factor, Forecasting, Corporation, POM, U.S. Securities and Exchange Commission, Senior, EBIT, Industry, Technology, Goal, Polymerization, Tax, Income, Non-use value, Stock dilution, Income tax, Engineering, Security (finance), Fine chemical, Carbon fibers, Bank, Insurance, Celanese, Celanese, MGC

Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced the completion of the restructuring of Korea Engineering Plastics Co. (KEP), a joint venture owned 50 percent by Celanese and 50 percent by Mitsubishi Gas Chemical Company, Inc. (MGC), as previously announced in December 2020.

Key Points: 
  • Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today announced the completion of the restructuring of Korea Engineering Plastics Co. (KEP), a joint venture owned 50 percent by Celanese and 50 percent by Mitsubishi Gas Chemical Company, Inc. (MGC), as previously announced in December 2020.
  • This restructuring will also allow Celanese greater access to original equipment manufacturers in Asia, as well as more direct participation in key markets outside of China.
  • Celanese maintains typical governance rights of the KEP joint venture and is excited to create further value from its 50 percent stake in KEP through this restructuring.
  • Celanese expects the restructuring of the KEP venture to be immediately accretive to adjusted EBIT and adjusted EPS.

Aspen Laser Becomes BOC Approved Provider for Athletic Trainers

Retrieved on: 
Friday, April 1, 2022
PBMT, Company, Board of Certification, Inc., Organization, CE, ASPEN, Class, Board, INC, Athletic, BOC, Laser, Athletic trainer, LLC, Industry, ATS, Science, Athlete, Partnership, 3D printing, Medical device, Certification

LINDON, Utah., April 1, 2022 /PRNewswire/ -- ASPEN LASER, LLC, an emerging global leader in the medical device industry with a focus on photomedicine announced its recent partnership with the Board of Certification, Inc. (BOC), the certifying organization for Athletic Trainers (AT). As a BOC Approved Provider

Key Points: 
  • As a BOC Approved Provider
    (Provider # P12065), Aspen Laser can now offer BOC certified educational programs to any AT.
  • "We are excited for Aspen Laser to be an approved BOC Provider, as it reinforces our commitment to providing high quality continuing education courses," stated Charles Vorwaller, CEO Aspen Laser Systems, LLC.
  • Through the BOC Approved Provider program, the BOC ensures CE programs are of high quality, requiring BOC Approved Providers to maintain annual approval and adherence to set "Standards for BOC Approved Providers" (Standards) and "Policies & Procedures for BOC Approved Providers" (Policies & Procedures).
  • Athletic Trainers can sign up for the Aspen Laser course Class IV Laser Certification Course for Athletic Trainers at the Aspen Laser University website: https://www.aspenlaseru.com/ ; or the ICEU online educational website: https://iceu.com/course/Class-IV-Laser-Certification-Course-for-Athletic...
    According to Vorwaller, "Aspen Laser is currently working with a number of amateur (college) and professional athletic trainers and sports teams.

Medscape, American College of Cardiology Launch Latin America Center for Cardiovascular Health Promotion

Retrieved on: 
Friday, April 1, 2022
Thrombosis, ACC, College, Leadership, CE, Nursing, Multimedia, CME, Health policy, Research, Hospital, MPH, Cardiovascular disease, FACC, View, Health, Center, Knowledge, American College of Cardiology, American College, International, Physician, Accreditation, News, Atrial fibrillation, Content, Heart failure, Patient, Pharmaceutical industry, Medicine, MD, Cardiology, Medscape

Leveraging the ACC's global leadership in cardiovascular care with that of Medscape, the leading global news and information platform for physicians, the new initiative will provide updates and insights, in both Spanish and Portuguese, on the latest research and emerging clinical trends in heart failure, atrial fibrillation, anticoagulation, thromboembolism, and lipid management -- all from the perspective of regional experts and thought-leaders. 

Key Points: 
  • NEW YORK, April 1, 2022 /PRNewswire/ -- Medscape and the American College of Cardiology (ACC) today announced the launch of the Latin America Center for Cardiovascular Health Promotion ( Spanish and Portuguese ), a new collaboration that will deliver trusted scientific information and resources on cardiovascular disease, specifically targeted to the patient care needs of physicians throughout Latin America.
  • "The ACC is mission-driven, aiming to transform cardiovascular care and improve heart health on a global scale," Cesar J. Herrera, MD, FACC, Latin America Representative, ACC Assembly of International Governors Steering Committee said.
  • The American College of Cardiology envisions a world where innovation and knowledge optimize cardiovascular care and outcomes.
  • As the professional home for the entire cardiovascular care team, the mission of the College and its 54,000 members is to transform cardiovascular care and to improve heart health.

PESI, Inc., Launches therapist.com, an Online Therapist Directory

Retrieved on: 
Thursday, March 31, 2022
Nursing, PESI, Counselor, EAU, CE, Directory, Mental health, Collection, Medicine

EAU CLAIRE, Wis., March 31, 2022 /PRNewswire/ -- The all-new therapist directory and educational resource therapist.com has been launched by PESI Inc., a nonprofit continuing education company with more than 40 years of experience training millions of therapists around the world. Therapist.com connects licensed mental health professionals with people who need help while offering resources to support clinicians and the general public. Interested professionals can currently register for a free one-year listing on the directory.

Key Points: 
  • Therapist.com connects licensed mental health professionals with people who need help while offering resources to support clinicians and the general public.
  • Interested professionals can currently register for a free one-year listing on the directory .
  • Clients, in turn, can select and build trust in their therapist before they even begin treatment.
  • When clinicians register for therapist.com, they get 12 months of free promotion on the directory and access to valuable professional resources.